Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.
Maurillo L, Del Poeta G, Venditti A, Buccisano F, Battaglia A, Santinelli S, Caravita T, Epiceno AM, Del Moro B, Tamburini A, Picardi A, Suppo G, Catalano G, Bruno A, Amadori S. Maurillo L, et al. Among authors: catalano g. Haematologica. 2001 Mar;86(3):237-43. Haematologica. 2001. PMID: 11255269
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors.
Bruno A, Caravita T, Adorno G, Del Poeta G, Venditti A, Stasi R, Ballatore G, Del Proposto G, Lanti A, Zinno F, Cudillo L, Dentamaro T, Buccisano F, Tamburini A, Santinelli S, Maurillo L, Cantonetti M, Cox MC, Masi M, Catalano G, Isacchi G, Amadori S. Bruno A, et al. Among authors: catalano g. Transfus Apher Sci. 2002 Apr;26(2):103-10. doi: 10.1016/s1473-0502(01)00157-4. Transfus Apher Sci. 2002. PMID: 12121064
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Picardi A, Fabritiis Pd Pd, Cudillo L, Dentamaro T, Cupelli L, Ballatore G, Venditti A, Caravita T, Cristina Cox M, Catalano G, Amadori S. Picardi A, et al. Among authors: catalano g. Hematol J. 2004;5(1):24-31. doi: 10.1038/sj.thj.6200357. Hematol J. 2004. PMID: 14745426 Clinical Trial.
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
Del Poeta G, Del Principe MI, Maurillo L, Rossi FM, Buccisano F, Ammatuna E, Simotti C, Zucchetto A, Catalano G, Bulian P, Bruno A, Venditti A, De Fabritiis P, Gattei V, Amadori S. Del Poeta G, et al. Among authors: catalano g. Leuk Lymphoma. 2010 Jan;51(1):95-106. doi: 10.3109/10428190903350421. Leuk Lymphoma. 2010. PMID: 20001236
A case of SRSF2 mutation in chronic lymphocytic leukemia.
Garza E, Del Poeta G, Martínez-Losada C, Catalano G, Borgia L, Piredda ML, Fabiani E, Gattei V, Lo-Coco F, Noguera NI. Garza E, et al. Among authors: catalano g. Leuk Res Rep. 2016 Jun 23;6:11-4. doi: 10.1016/j.lrr.2016.03.001. eCollection 2016. Leuk Res Rep. 2016. PMID: 27453816 Free PMC article.
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Catalano G, Zaza A, Banella C, Pelosi E, Castelli G, de Marinis E, Smigliani A, Travaglini S, Ottone T, Divona M, Del Principe MI, Buccisano F, Maurillo L, Ammatuna E, Testa U, Nervi C, Venditti A, Voso MT, Noguera NI. Catalano G, et al. Leukemia. 2023 Aug;37(8):1600-1610. doi: 10.1038/s41375-023-01946-5. Epub 2023 Jun 22. Leukemia. 2023. PMID: 37349598
726 results